ActiveSite Pharmaceuticals, Inc.
Berkeley, USA
|
Description:
ActiveSite Pharmaceuticals utilizes the discovery technology to discover new small molecule drug candidates for human diseases with unmet medical need. The company is focused on developing treatments for the vision-threatening complication of diabetes, diabetic macular edema, and the genetic disease hereditary angioedema, by targeting the vascular protease plasma kallikrein.
ActiveSite Pharmaceuticals utilizes the discovery technology to discover new small molecule drug candidates for human diseases with unmet medical need. The company is focused on developing treatments for the vision-threatening complication of diabetes, diabetic macular edema, and the genetic disease hereditary angioedema, by targeting the vascular protease plasma kallikrein.